MedPath
FDA Approval

PHENDIMETRAZINE TARTRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 7, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phendimetrazine(35 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Elite Laboratories, Inc.

785398728

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Elite Laboratories, Inc.

Elite Laboratories, Inc

Elite Laboratories, Inc.

785398728

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHENDIMETRAZINE TARTRATE

Product Details

NDC Product Code
64850-440
Application Number
ANDA040762
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 7, 2019
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
Code: 6985IP0T80Class: ACTIBQuantity: 35 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
SODIUM STARCH GLYCOLATE TYPE A CORNInactive
Code: AG9B65PV6BClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath